Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Assets: 2010-2024

Historic Assets for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to $14.9 million.

  • China Pharma Holdings' Assets rose 17.37% to $15.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.8 million, marking a year-over-year increase of 17.37%. This contributed to the annual value of $14.9 million for FY2024, which is 9.60% down from last year.
  • Per China Pharma Holdings' latest filing, its Assets stood at $14.9 million for FY2024, which was down 9.60% from $16.5 million recorded in FY2023.
  • China Pharma Holdings' Assets' 5-year high stood at $22.6 million during FY2021, with a 5-year trough of $14.9 million in FY2024.
  • In the last 3 years, China Pharma Holdings' Assets had a median value of $16.5 million in 2023 and averaged $16.4 million.
  • Per our database at Business Quant, China Pharma Holdings' Assets increased by 7.25% in 2021 and then fell by 21.48% in 2022.
  • China Pharma Holdings' Assets (Yearly) stood at $21.1 million in 2020, then grew by 7.25% to $22.6 million in 2021, then declined by 21.48% to $17.8 million in 2022, then fell by 7.39% to $16.5 million in 2023, then fell by 9.60% to $14.9 million in 2024.